Localized BCNU chemotherapy and the multimodal management of malignant glioma

A phase II trial (N0177) of erlotinib and temozolomide (TMZ) combined with radiation therapy (RT) in glioblastoma multiforme (GBM)

(2017) P. D. Brown et al.   JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab (B) plus irinotecan (I) in progressive multiple pretreated and temozolomide (T) refractory glioblastoma multiforme (GBM): A single center experience using a low dose regimen

(2017) A. Dresemann et al.   JOURNAL OF CLINICAL ONCOLOGY

Combination of bevacizumab plus irinotecan in recurrent malignant gliomas (MG): A retrospective study of efficacy and safety

(2017) M. J. Gil Gil Sr. et al.   JOURNAL OF CLINICAL ONCOLOGY

A single institution’s experience with bevacizumab and cytoxic chemotherapy in progressive malignant glioma

(2017) T. M. Mayer et al.   JOURNAL OF CLINICAL ONCOLOGY

Retrospective analysis of patterns of recurrence seen on MRI in patients with recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan

(2017) R. M. Zuniga et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of EGFRvIII-targeted vaccine (CDX-110) on immune response and TTP when given with simultaneous standard and continuous temozolomide in patients with GBM

(2017) J. H. Sampson et al.   JOURNAL OF CLINICAL ONCOLOGY

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

(2009) et al.   NEUROSURGERY

Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years?

(2008) E. Anderson et al.   BRITISH JOURNAL OF NEUROSURGERY

Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience

(2008) Michael Sabel et al.   CURRENT MEDICAL RESEARCH AND OPINION

Brain Tumor Stem Cells

(2008) Erik Sulman et al.   CURRENT PROBLEMS IN CANCER

Just Enough Palliation: Radiation Dose and Outcome in Patients With Non–Small-Cell Lung Cancer

(2008) Henry Wagner   JOURNAL OF CLINICAL ONCOLOGY

In Reply

(2008) Pascal Pommier et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan

(2008) Sith Sathornsumetee et al.   JOURNAL OF CLINICAL ONCOLOGY

A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients

(2008) Edward Pan et al.   JOURNAL OF NEURO-ONCOLOGY

Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme

(2008) Borimir J. Darakchiev et al.   JOURNAL OF NEUROSURGERY

Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors

(2007) Mizuhiko Terasaki et al.   SURGICAL NEUROLOGY